Accordingly, the overwhelming majority of tumour tissues from NSCLC patients (17/18 cases) exhibited lower protein levels of USP12 than the corresponding non-tumour tissues (Fig. 1g). This evidence concerns the gene USP12 and non-small cell lung carcinoma.